The RM Partners Medicines Optimisation group is hosting another in its series of successful pan-London education evenings on Wednesday 1 May 2019, with a focus …
Read moreLatest news and blogs
New pan-London research fellowships launched
A new programme of 12-month London-based research fellowships is being launched by the three Cancer Alliances across London for 2019/20. This is an exciting opportunity …
Read moreRecruitment open for chair of RM Partners Lung Cancer Pathway Group
RM Partners is recruiting a new chair for the Lung Cancer Pathway Group. This is an exciting opportunity to deliver cancer transformation and influence the …
Read moreNew year education event on pharmacy oncology
The RM Partners Medicines Optimisation group is hosting the second pan-London education evening on Wednesday 16 January 2019, with a focus on ‘ESMO Highlights’. The …
Read moreBowel screening reminder service a success
The RM Partners pilot to increase uptake bowel screening across south west London has proven incredibly successful. All six CCGs in the area took part, …
Read moreCelebrating our impact and achievements
The RM Partners Annual Review, which celebrates our transformational cancer work across west London, has now been published. The review contains a number of examples …
Read moreLung health checks benefitting hundreds of west Londoners
Over 500 people in Hillingdon and Hammersmith and Fulham have already participated in the RM Partners pilot project to help pick up lung cancer earlier. …
Read moreRAPID wins HSJ award for innovation

Our RAPID (Rapid Access to Prostate Imaging and Diagnosis) project won the prestigious HSJ Award for Acute …
Read moreSocial media campaign to increase cervical screening uptake
RM Partners, in partnership with the Hammersmith and Fulham GP Federation, is running a social media campaign to raise awareness of a new service encouraging …
Read moreRAPID prostate pathway videos launched
Two videos explaining the new RAPID (Rapid Access to Prostate Imaging and Diagnosis) pathway to diagnose suspected prostate cancer have been produced by RM Partners. The …
Read more